These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 14379741)

  • 1. Isolation of a cancer-specific antigen.
    LUND H
    Dan Med Bull; 1955 May; 2(3):73-82. PubMed ID: 14379741
    [No Abstract]   [Full Text] [Related]  

  • 2. Antibody-based identification of cell surface antigens: targets for cancer therapy.
    Loo DT; Mather JP
    Curr Opin Pharmacol; 2008 Oct; 8(5):627-31. PubMed ID: 18804182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct access to CD4+ T cells specific for defined antigens according to CD154 expression.
    Frentsch M; Arbach O; Kirchhoff D; Moewes B; Worm M; Rothe M; Scheffold A; Thiel A
    Nat Med; 2005 Oct; 11(10):1118-24. PubMed ID: 16186818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined staining of TAG-72, MUC1, and CA125 improves labeling sensitivity in ovarian cancer: antigens for multi-targeted antibody-guided therapy.
    Chauhan SC; Vinayek N; Maher DM; Bell MC; Dunham KA; Koch MD; Lio Y; Jaggi M
    J Histochem Cytochem; 2007 Aug; 55(8):867-75. PubMed ID: 17478446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in specific immunotherapy for prostate cancer.
    Kiessling A; Füssel S; Wehner R; Bachmann M; Wirth MP; Rieber EP; Schmitz M
    Eur Urol; 2008 Apr; 53(4):694-708. PubMed ID: 18061335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibodies and vaccines--hope or illusion?
    Jäger D; Knuth A
    Breast; 2005 Dec; 14(6):631-5. PubMed ID: 16242931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and evaluation of polystyrene-antigen conjugates for the isolation of antibodies.
    GYENES L; SEHON AH
    Can J Biochem Physiol; 1960 Nov; 38():1235-48. PubMed ID: 13710122
    [No Abstract]   [Full Text] [Related]  

  • 8. Selective monomorphic and polymorphic HLA class I antigenic determinant loss in surgically removed melanoma lesions.
    Kageshita T; Ishihara T; Campoli M; Ferrone S
    Tissue Antigens; 2005 May; 65(5):419-28. PubMed ID: 15853896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intact HLA not beta2m-free heavy chain-specific HLA class I antibodies are predictive of graft failure.
    Cai J; Terasaki PI; Anderson N; Lachmann N; Schönemann C
    Transplantation; 2009 Jul; 88(2):226-30. PubMed ID: 19623018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The usefulness of ELISA test for early serological detection of Trichinella spp. infection in pigs].
    Bień J
    Wiad Parazytol; 2007; 53(2):149-51. PubMed ID: 17912813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-tumor antibodies in ovarian cancer.
    Luborsky JL; Barua A; Shatavi SV; Kebede T; Abramowicz J; Rotmensch J
    Am J Reprod Immunol; 2005 Aug; 54(2):55-62. PubMed ID: 16105096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seroreactivity to specific antigens of Helicobacter pylori infection is associated with an increased risk of the dyspeptic gastrointestinal diseases.
    Chomvarin C; Ottiwet O; Hahnvajanawong C; Intapan PM; Wongwajana S
    Int J Infect Dis; 2009 Sep; 13(5):647-54. PubMed ID: 19233700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Highly specific detection of antibodies to tick-borne encephalitis (TBE) virus in humans using a domain III antigen and a sensitive immune complex (IC) ELISA.
    Ludolfs D; Reinholz M; Schmitz H
    J Clin Virol; 2009 Jun; 45(2):125-8. PubMed ID: 19409841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolating recombinant antibodies against specific protein morphologies using atomic force microscopy and phage display technologies.
    Barkhordarian H; Emadi S; Schulz P; Sierks MR
    Protein Eng Des Sel; 2006 Nov; 19(11):497-502. PubMed ID: 16984950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Purification of colorectal cancer-associated antigen by immuno-affinity chromatography].
    Yang Y; Li Y; Wang XH; Shang P; Wang L; Qian AR; Yao XY; Chen ZN
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 May; 20(3):348-51. PubMed ID: 15193236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T-cell receptor-like antibodies: novel reagents for clinical cancer immunology and immunotherapy.
    Noy R; Eppel M; Haus-Cohen M; Klechevsky E; Mekler O; Michaeli Y; Denkberg G; Reiter Y
    Expert Rev Anticancer Ther; 2005 Jun; 5(3):523-36. PubMed ID: 16250828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapeutic experiment on mouse cancer with a cancer antigen].
    HECHT H
    Oncologia; 1955; 8(1):46-54. PubMed ID: 14394615
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of pre-existent immunity in patients with primary breast cancer: molecular and cellular assays to quantify antigen-specific T lymphocytes in peripheral blood mononuclear cells.
    Rentzsch C; Kayser S; Stumm S; Watermann I; Walter S; Stevanoviç S; Wallwiener D; Gückel B
    Clin Cancer Res; 2003 Oct; 9(12):4376-86. PubMed ID: 14555509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sperm-associated antigen 9, a novel cancer testis antigen, is a potential target for immunotherapy in epithelial ovarian cancer.
    Garg M; Chaurasiya D; Rana R; Jagadish N; Kanojia D; Dudha N; Kamran N; Salhan S; Bhatnagar A; Suri S; Gupta A; Suri A
    Clin Cancer Res; 2007 Mar; 13(5):1421-8. PubMed ID: 17332284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of native and recombinant cytomegalovirus antigens in a new ELISA for detection of CMV-specific antibodies.
    Busse C; Strubel A; Schnitzler P
    J Clin Virol; 2008 Oct; 43(2):137-41. PubMed ID: 18621576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.